We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Biosimilars Market is Likely to Grow at a Compound Annual Growth Rate of 49.1% from 2015 to 2020

Article   Aug 10, 2018 | by Srushti Helwande, Allied Market Research

 
The Biosimilars Market is Likely to Grow at a Compound Annual Growth Rate of 49.1% from 2015 to 2020
 
 
 

RELATED ARTICLES

Optimizing Starting Material Quality for Cellular Therapeutics

Article

When a company strives to make an excellent product, they start with the highest quality materials. Cell therapy is unique in that the building blocks for the “product” are living human cells; since each donor is unique, variability is inevitable. Choosing optimal apheresis instrumentation and collection methods is one of the most important steps in ensuring high-quality starting material.

READ MORE

The New Normalization in Western Blotting

Article

A western blot is supposed to give you information on true experimental conditions or differences between samples. It is instrumental for the detection of proteins in research discovery and biopharma. In this article, we will be explaining the two main western blotting normalization methods; the older housekeeping protein method and the newer TPN method.

READ MORE

Current Trends in Bispecifics, Dual-action and Combination Therapies

Article

It’s becoming increasingly apparent that treatments for complex diseases such as cancer, neurodegenerative diseases and depression are unlikely to target a single molecule in the pathological pathway. Drug developers are turning to new ways to exploit more than one drug target at a time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE